Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
In re: Juniper Networks, Inc., Appeal No. 2021-160 (Fed. Cir. Sept. 24, 2021)
In this week’s Case of the Week, the Federal Circuit issued its fifth writ of mandamus this year ordering transfer of a patent case out of the Western District of Texas courtroom of U.S. District Court Judge Alan D. Albright.
(Our write-up of the recent precedential decision in In re Samsung is available here.)
In this case, the Court ordered the transfer of infringement cases brought by non-practicing entity WSOU Investments LLC d/b/a Brazos Licensing and Development (“Brazos”) against petitioner Juniper from the Western District of Texas to the Northern District of California. Brazos’s only presence in the Western District of Texas was a two-person office it had recently opened in Waco for the purpose of filing patent lawsuits, whereas the accused products had been primarily designed, developed, marketed, and sold from Juniper’s headquarters in the Northern District of California. The Court found that in denying Juniper’s transfer motion, Judge Albright again erred in his analysis and weighing of multiple transfer factors under 28 U.S.C. § 1404(a), including the relative convenience of witnesses, local interests in adjudicating the dispute, the availability of sources of proof, the potential need for compulsory process, and considerations of court congestion.
Read More.
Edited by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
Contributor: Jason Wrubleski
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…